MODULATION OF EXPERIMENTAL ARTHRITIS IN MICE BY GPI-ANCHORED PROTEIN TRANSFER

通过 GPI 锚定蛋白转移调节小鼠实验性关节炎

基本信息

  • 批准号:
    6235662
  • 负责人:
  • 金额:
    $ 10.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-07-01 至 1998-06-30
  • 项目状态:
    已结题

项目摘要

Collagen-induced arthritis (CIA) in mice is an experimental model of rheumatoid arthritis (RA) that closely mimics the human disorder both clinically and immunopathologically. As in human RA, susceptibility to the disease maps to a subregion (the I-A) of class II MHC and injury to cartilage type II collagen results from both T cell-mediated and humoral immune mechanisms. A recently emerging body of evidence has indicated that one class of cell surface proteins has the unusual property, both in vitro and in vivo, of being able to transfer from one cell type to another. The proteins that possess this capability are proteins that are membrane- anchored by glycoinositolphospholipid (GPI) units. Importantly, it additionally has been demonstrated that these proteins, when purified and added directly to cells, insert themselves into the target cells, and once incorporated, are fully functional. Among the proteins in this class are two critical inhibitors of humoral immune attack [the decay accelerating factor (DAF) or CD55 and the membrane inhibitor of reactive lysis (MIRL) or CD59]. By recombinant DNA technology, it has been shown that it is possible to re-engineer other key regulators of humoral and cellular immune attack so as to possess GPI anchors. This feasibility study is directed at examining new experimental methods for delivery of these GPI- containing regulators to inflamed joints using both transgenic animals expressing the proteins and the purified proteins themselves. The data obtained could have relevance to new treatment modalities for RA and other rheumatic diseases.
胶原诱导的关节炎(CIA)是小鼠的实验模型

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MELVIN EDWARD MEDOF其他文献

MELVIN EDWARD MEDOF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MELVIN EDWARD MEDOF', 18)}}的其他基金

Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE
优化间充质干细胞和 Treg 免疫抑制以控制 SLE
  • 批准号:
    8964783
  • 财政年份:
    2015
  • 资助金额:
    $ 10.85万
  • 项目类别:
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE
优化间充质干细胞和 Treg 免疫抑制以控制 SLE
  • 批准号:
    9314221
  • 财政年份:
    2015
  • 资助金额:
    $ 10.85万
  • 项目类别:
Optimizing mesenchymal stem cell and Treg immunosuppression for controlling SLE
优化间充质干细胞和 Treg 免疫抑制以控制 SLE
  • 批准号:
    9105570
  • 财政年份:
    2015
  • 资助金额:
    $ 10.85万
  • 项目类别:
Local Complement Synthesis and Signaling by Endothelial and Inflammatory Cells
内皮细胞和炎症细胞的局部补体合成和信号传导
  • 批准号:
    8373385
  • 财政年份:
    2012
  • 资助金额:
    $ 10.85万
  • 项目类别:
Local Complement Synthesis and Signaling by Endothelial and Inflammatory Cells
内皮细胞和炎症细胞的局部补体合成和信号传导
  • 批准号:
    8517802
  • 财政年份:
    2012
  • 资助金额:
    $ 10.85万
  • 项目类别:
Local Complement Synthesis and Signaling by Endothelial and Inflammatory Cells
内皮细胞和炎症细胞的局部补体合成和信号传导
  • 批准号:
    8678990
  • 财政年份:
    2012
  • 资助金额:
    $ 10.85万
  • 项目类别:
Role of DAF in the Complement Cascade
DAF 在补体级联中的作用
  • 批准号:
    7891024
  • 财政年份:
    2009
  • 资助金额:
    $ 10.85万
  • 项目类别:
Pathogenic Mechanisms Underlying Diabetic Retinopathy
糖尿病视网膜病变的发病机制
  • 批准号:
    6904443
  • 财政年份:
    2004
  • 资助金额:
    $ 10.85万
  • 项目类别:
Pathogenic Mechanisms Underlying Diabetic Retinopathy
糖尿病视网膜病变的发病机制
  • 批准号:
    7287402
  • 财政年份:
    2004
  • 资助金额:
    $ 10.85万
  • 项目类别:
Pathogenic Mechanisms Underlying Diabetic Retinopathy
糖尿病视网膜病变的发病机制
  • 批准号:
    6762097
  • 财政年份:
    2004
  • 资助金额:
    $ 10.85万
  • 项目类别:

相似海外基金

ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145834
  • 财政年份:
    1990
  • 资助金额:
    $ 10.85万
  • 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145832
  • 财政年份:
    1990
  • 资助金额:
    $ 10.85万
  • 项目类别:
ROLE OF CD4/CD8 MOLECULE IN T CELL SPECIFICITY
CD4/CD8 分子在 T 细胞特异性中的作用
  • 批准号:
    3145835
  • 财政年份:
    1990
  • 资助金额:
    $ 10.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了